Zimmer Biomet (ZBH) PT Lowered to $161 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $112.11 +15.51%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Join SI Premium – FREE
BTIG analyst Ryan Zimmerman lowered the price target on Zimmer Biomet (NYSE: ZBH) to $161.00 (from $173.00) while maintaining a Buy rating.
You May Also Be Interested In
- Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; updates guidance
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
- Cinemark Holdings (CNK) PT Raised to $45 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
